Key result
Polycystic ovary syndrome is associated with a higher risk of cardiovascular diseases linked to metabolic dysfunction, hyperandrogenism, insulin resistance, dyslipidemia, and an inflammatory state.
PCOS should be considered a significant cardiovascular risk factor due to its association with metabolic syndrome, hypertension, and vascular abnormalities.
Answers are grounded in this paper and cite their sources.
May prompt CV risk assessment in PCOS; leaves open need for interventional trials.
Polycystic ovary syndrome (PCOS), or Stein-Leventhal syndrome, is a common endocrine disorder defined by two of the three following features: i) oligoovulation or anovulation, ii) clinical and/or biochemical signs of hyperandrogenism, or iii) polycystic ovaries, once the related endocrinological and gynaecological disorders have been excluded. PCOS does not exclusively involve the reproductive apparatus , it has a complex number of systemic relevancy symptoms. It leads to Metabolic Syndrome, with severe consequences on the cardiovascular apparatus. Many clinical studies have underlined the connection between PCOS and the cardiovascular risk profile of such female patients, due to a lipid/glucose altered metabolism, hypertension, systemic inflammatory condition (assessable by markers such as VES, TNF-alfa, citokines and C-reactive protein (hsPCR) levels), and vascular injuries. Considering the early onset of the disease, PCOS could be considered as a real cardiovascular risk factor which affects the quality of life seriously. The current review aimed to point out the main connections between PCOS and cardiovascular risk factors according to the latest findings coming from literature data analysis, and try to depict the great influences that such a common disease can have on the patients' health integrity.
No takes yet. Share an insight, caveat, or question.
Scicchitano et al. (2012) conducted a review in Polycystic Ovary Syndrome (PCOS). Polycystic Ovary Syndrome (PCOS) vs. Women without PCOS was evaluated. Polycystic ovary syndrome is associated with a higher risk of cardiovascular diseases linked to metabolic dysfunction, hyperandrogenism, insulin resistance, dyslipidemia, and an inflammatory state.
Synapse has enriched 10 related papers. Consider them for comparative context: